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Abstract 
The focus of this research was to decrease inflammatory-related liver damage from 
tamoxifen in rats by adding fish oil to the diet.  Tamoxifen causes a significant increase 
in inflammation of the liver.  Inflammation increases with the production of 
prostaglandins by a metabolic pathway involving arachidonic acid.  The metabolism of 
tamoxifen by the enzyme cytochrome P450 leads to an increase in the production of 
prostaglandins.  The increased inflammation is proportional to lipid accumulation and 
ultimately lipid peroxidation in the liver.  Resulting damage in humans includes hepatic 
steatosis (fatty liver), nonalcoholic steatohepatitis (NASH), and cirrhosis.  Fish oils rich 
in omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosahexanoic acid 
(DHA), should decrease inflammation by indirectly suppressing the production of 
prostaglandins through enzymatic competition.  Female rats were given a 7-day treatment 
of tamoxifen (35mg/kg) and/or fish oil (1000 mg/kg) by IP injection.  Total rat weights 
were significantly lower in rats receiving only tamoxifen and significantly greater in rats 
receiving only fish oil, with no significant difference in the control rats or the rats 
receiving both variables.  Liver weights exhibit no significant differences.  Liver lipid 
analyses showed a significant decrease in lipid accumulation in rats that received both 
tamoxifen and fish oil.  A significant decrease in lipid peroxidation was prominent in the 
rats that only received fish oil, possibly a result of its antioxidant activity.  Future work 
may include increasing the numbers of rats and identifying proteins, estrogen 
metabolites, and tamoxifen metabolites, as well using a TBARS analysis for lipid 
peroxidation. 
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Introduction 
Tamoxifen is a widely used drug in the treatment of breast cancer.  It is classified as a 
selective estrogen receptor modulator (SERM).  The active metabolite, 4-
hydroxytamoxifen, blocks the estrogen receptor sites to inhibit growth of tumor cells in 
the mammary gland.  It is metabolized by a cytochrome P450 enzyme in the liver.  The 
metabolism of drugs by cytochrome P450 results in reactive intermediates that increase 
liver damage [10].  It also affects the biotransformation of eicosanoids, including 
prostaglandins [11]. 
Non-alcoholic steatohepatitis (NASH) is associated with the chronic use of tamoxifen.  It 
is caused by chronic inflammation, fibrosis, and lipid accumulation of the liver.  
Mechanisms of damage include mitochondrial dysfunction, the overproduction of 
reactive oxygen species (ROS), and lipid peroxidation [2].  Fish oils rich in omega-3 fatty 
acids, including eicosapentanoic acid (EPA) and docosahexanoic acid (DHA), may 
decrease damage by preventing inflammation.  Omega-3 fatty acids and omega-6 fatty 
acids utilize the same metabolic enzymes, and therefore enzymatic competition occurs 
when omega-3 fatty acid metabolism is increased (see Figure 1).  The metabolism of 
omega-6 fatty acids produces arachidonic acid, which results in the production of 
prostaglandins.  Prostaglandins are classified as an eicosanoid that results in 
inflammation in both normal and tumor cells.  Their production is inhibited by an 
increase in omega-3 fatty acids, found in fish oils. 
Figure 1.  Metabolic route of fatty acids [8]. 
Fish oils may result in an increase in lipid peroxidation products.  Lipid peroxidation 
occurs when double bonds in lipids and fatty acids are broken down by ROS, and result 
in free radical formation [12].  However, fish oils increase superoxide dismutase (SOD) 
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and glutathione peroxidase, which protect tissues from lipid peroxidation [7].  Also, there 
is less lipid peroxidation if the fish oil is natural, relatively stable, and is in concentration 
less than 38% [15].  Fish oils are also beneficial to breast cancer patients by inhibiting 
eicosanoid production in cancer cells to inhibit their growth [14], and by increasing the 
efficacy of anticancer drugs [6, 9]. 
Methods 
Experimental Animals: 
MSU’s colony of female Wistar Kyoto (WKY) rats at 10 weeks of age, weighing 249 ± 
44 g were given access to rat chow and water, with 2-3 rats/cage, and were acclimated for 
two weeks prior to experimentation.  They were randomly placed into four groups of five 
rats each, as follows (see Table 1): Group A – 0.2 ml tricaprylin vehicle and 0.3 ml 
saline solution; Group B – 0.2 ml of tamoxifen (35 mg/kg) with tricaprylin vehicle and 
0.3 ml saline solution; Group C –0.3 ml fish oil from Menhaden (1000 mg/kg) and 0.2 
ml tricaprylin vehicle; and Group D – 0.2ml of tamoxifen (35 mg/kg) with tricaprylin 
vehicle and 0.3 ml fish oil from Menhaden (1000 mg/kg).  Intraperintoneal (IP) injections 
of all four groups were performed for seven days, accordingly, and euthanized by carbon 
dioxide on the eighth day.  
Table 1.  Injected variables for each group of female rats. 
Group A B C D
Tricaprylin X X X X 
Tamoxifen citrate (35mg/kg) 
(Sigma-Aldrich) 
X X
Fish Oil (1000 mg/kg) 
(OmegaPure, 25% EPA/DHA) 
 X X
Saline Solution X X 
Lipid accumulation & cirrhosis: 
Livers were perfused with approximately 50 ml of 0.9% NaCl solution, and excised from 
the body.  Weights and colors of rat livers were recorded for analysis of lipid 
accumulation and cirrhosis.   
Liver microsomal preparation: 
Liver microsomes, drug-metabolizing enzymes including cytochrome P450, were 
prepared by a standard method by Omura and Sato [13].  Livers were halved (one half for 
later use), and weights were recorded.  Excised livers were finely chopped and 
homogenized with 4 volumes of 1mM EDTA and 0.25 M sucrose.  10 uL of homogenate 
were stored in a test tube for later use.  The homogenate was centrifuged at 9000 X G 
(Rotor JS13.1: 7576 RPM) for 10 minutes at 4° C.  Precipitate was discarded and the 
resulting sediment microsomes were centrifuged at 112700 X G (Rotor SW27: 25000 
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RPM) for 60 minutes.  The upper layer was removed and the pellet was resuspended in 
0.1 M phosphate buffer, pH 7.0, and stored at 4° C. 
Cytochrome P450 Concentration: 
Cytochrome P450 (CYP) concentration was measured by standard methods by Omura 
and Sato [13] and Conney [4].  The microsomes were suspended in 0.1 M phosphate 
buffer (pH 7.0).  Using a dual-beam spectrophotometer, a baseline was accomplished by 
running untreated microsomes in 1-cm square sample and reference cuvettes from 350 
nm to 550 nm.  The sample cuvette’s contents were reduced in a few milligrams of solid 
sodium dithionate.  Carbon monoxide was then bubbled into the sample cuvette.  A 
second scan determined CYP concentration by using the ΔΑ450−500 (peak-trough) and the 
extinction coefficient of 91 mM-1 cm-1. 
Protein Quantification: 
Protein quantification by Bradford assay [3] will aids in the measurement of CYP and 
corresponds to lipid production in the liver.  A standard curve was prepared according to 
Table 2, using a 1.0 mg/ml bovine serum albumin (BSA) solution in distilled H2O.  5 ml 
of Bradford reagent were added to 100 uL of sample, incubated at room temperature for 5 
minutes, and placed in spectrophotometer at 595nm.  Protein quantity was calculated 
using a standard curve based on the Table 2.  
Table 2.  Bradford assay recipe for preparing solutions for standard curve at A=595 nm. 
μL dH20  μL BSA Solution 100 μL Final Standard
100  0  0
90  10  10
75  25  25
50  50  50
25  75  75
0  100  100
Lipid Accumulation: 
To further analyze lipid accumulation, total lipids were extracted and purified by an 
accepted method by Folch et al [5].  Liver tissues were homogenized with 2:1 
chloroform-methanol mixture (v/v) and butylated hydroxytoluene (BHT) (5 mg/100ml) 
to a final dilution 20-fold the volume of the tissue sample.  BHT was added to the sample 
to reduce oxidation.  Homogenate was filtered and washed with 20% of the volume of 
water.  Mixture was allowed to separate, and the upper layer was removed.  Methanol 
was added, and the resulting solution was diluted to final volume with the 2:1 
chloroform-methanol mixture.  After 2 ml of water was added to the solution in a 
centrifuge tube, the sample was mixed and centrifuged until complete separation 
occurred.  The resulting pellet was dried and weighed. 
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Lipid Peroxidation: 
Lipid peroxidation was measured using an enzyme immunoassay kit for 9(±)-
hydroxydecadienoic acid (Oxford Biochemical Research, Inc.).  Extracted lipids were 
diluted with 4 ml methanol, containing 5 mg BHT/100 ml and an equal volume of 15% 
KOH.  Samples were placed in a water bath at 37° C for 30 minutes.  Samples were then 
acidified to pH 3 using 1 N HCl, and diluted to 80 ml with pH 3 water.  Water saturated 
ethyl acetate was added (3X sample volume), and sample was centrifuged at low speed 
for extraction.  Organic phase and removed and transferred to clean test tube.  Samples 
were then dried under nitrogen gas.  Bio-Rad Microplate Reader, Model 550, was used to 
determine standard curve and amount 9(±)-HODE present in each sample. 
Results 
Rat Total Body Weight: 
Rats were weighed prior to experimental period and then again after the seventh day of 
injections.  Pre and post weights were compared for significant differences.  Group A 
(control) gained a significant amount of weight; Group B (tamoxifen) lost a significant 
amount of weight; Group C (fish oil) gained a significant amount of weight; Group D 
showed no significant difference (see Figure 2).  Tamoxifen caused a weight loss, fish oil 
caused a weight gain, and fish oil restored the weight loss related to the addition of 
tamoxifen to the diet. 
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Figure 2.  Comparison of pre-study total rat weights and post-study total rat weights. 
* denotes a statistical difference.
Liver Weight & Degree of Cirrhosis: 
After excising each liver, weights were recorded and any discoloration was noted.  
Comparison of liver weights between each group showed no significant differences.  
Also, no discoloration was noted for any of the livers. 
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Total Lipids: 
Percent total lipids were calculated for each group.  It was found that a significant 
difference existed between Group A (control) and Group D (tamoxifen/fish oil) (see 
Table 2). 
Table 2.  Comparison of percent total lipid between the Group A (control) and Group D 
(tamoxifen/fish oil), after 7-day treatment. 
Group A Group D
Mean (percent total lipid) 5.1915 3.6053
Variance 0.7255 0.3085
P(T<=t) one-tail 0.0051
P(T<=t) two-tail 0.0102
Cytochrome P450: 
Microsomes were prepared in order to quantify cytochrome P450, the enzyme used in 
metabolizing tamoxifen in the liver.  During microsomal preparation, an error occurred 
that resulted in the breakdown of the products necessary for accurately quantifying 
cytochrome P450.  Therefore, this portion of the experimental analysis was inconclusive. 
Protein Quantification (Liver and Microsomal): 
Both the liver proteins and microsomal proteins were quantified by a Bradford assay.  No 
significant difference in liver proteins existed between the groups.  However, a 
significant difference in microsomal proteins existed between Group B (tamoxifen) and 
Group D (tamoxifen/fish oil), with a p-value of 0.017. 
Lipid Peroxidation: 
Lipid peroxidation was measured by quantifying conjugated dienes (9±-HODE) using a 
colorimetric immunoassay kit.  Resulting calculations (see Table 3) exhibited that Group 
C (fish oil) had significantly fewer lipid peroxidation products compared to all other 
groups, with a p-value of 0.029. 
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Table 3.  Lipid peroxidation statistics. 
Group Mean ± SE 
A 1739.70 ± 185.3 
B 1715.76 ± 254.3 
C 1229.50 ± 188.6 
D 1312.10 ± 456.9 
Conclusions 
Tamoxifen decreases body weight, while fish oil increases body weight in female rats.  
Fish oil restores the body weight when tamoxifen is administered to female rats, without 
increasing the percent of total lipids of the liver.  The combination of tamoxifen and fish 
oil decreases lipid accumulation in the liver through mechanisms related to preventing 
inflammation by decreasing prostaglandin production.   
Fish oil decreases lipid peroxidative damage in female rats.  This may be related to an 
increase in SOD and glutathione peroxidase in the liver, as a result of adding fish oil to 
the diet.   
Analyses of experimentation show that chronic affects were not seen in a 7-day treatment 
of tamoxifen.  However, acute affects have shown to be successful in the prevention of 
NASH, by preventing lipid accumulation of the liver and by decreasing lipid peroxidation 
products.   
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